In addition to using gemcitabine and the natural killer cells that are TGF-β imprinted, we also are combining an anti-GD2 antibody called naxitamab that's provided by Y-mAbs. Naxitamab, as I said, is ...
New study successfully made CTC-derived organoids from breast cancer patients' blood samples to investigate cell survival and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback